The duration of Calquence (acalabrutinib) treatment depends on the specific type of cancer being treated and whether the drug is used alone or in combination with other therapies.
How Long is Calquence Typically Prescribed?
For adults with mantle cell lymphoma (MCL) who have received at least one prior therapy, Calquence is generally taken continuously until disease progression or unacceptable toxicity [1]. Similarly, for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have received at least one prior therapy, or as a first-line treatment for CLL/SLL, treatment with Calquence is also typically continued until disease progression or unacceptable toxicity [1][2].
When Might Calquence Treatment Stop?
Treatment with Calquence may be discontinued if the cancer progresses or if a patient experiences side effects that are not manageable [1]. The decision to stop treatment is made in consultation with a healthcare provider, weighing the benefits of continued therapy against potential risks and side effects.
What is Calquence Used For?
Calquence is a targeted therapy used to treat certain types of blood cancers, specifically mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) [1][2]. It works by inhibiting a protein called Bruton's tyrosine kinase (BTK), which is important for the growth and survival of some cancer cells [3].
Can Treatment Durations Vary?
Yes, the precise duration of Calquence treatment can vary significantly based on individual patient factors, the specific disease subtype, and the treatment setting (first-line versus subsequent lines of therapy) [1][2]. Your doctor will determine the most appropriate treatment plan and duration for your specific situation.
What Are the Potential Side Effects of Calquence?
Common side effects of Calquence can include fatigue, diarrhea, and muscle or joint pain [1]. More serious side effects may also occur, and it is important to discuss any concerns with your healthcare provider.
When Do Calquence Patents Expire?
Information on the patent expiration dates for Calquence and its potential generic or biosimilar competition can be found on specialized resources like DrugPatentWatch.com [4]. These timelines are crucial for understanding when lower-cost treatment options might become available.
Sources
1. [https://www.mycancer.com/cancer-drugs/acalabrutinib-calquence/](https://www.mycancer stellate.com/cancer-drugs/acalabrutinib-calquence/)
2. https://www.mayoclinic.org/drugs-supplements/acalabrutinib-oral-route/proper-use/drg-20465316
3. https://www.cancer.gov/about-cancer/treatment/drugs/acalabrutinib
4. https://drugpatentwatch.com/